Leerink Partnrs Has Positive Outlook of OKUR FY2025 Earnings
OnKure Therapeutics (NASDAQ:OKUR – Free Report) – Equities research analysts at Leerink Partnrs raised their FY2025 EPS estimates for shares of OnKure Therapeutics in a note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst A. Berens now forecasts that the company will post earnings of ($4.03) per share for the year, up from […]
OnKure Therapeutics (NASDAQ:OKUR – Free Report) – Equities research analysts at Leerink Partnrs raised their FY2025 EPS estimates for shares of OnKure Therapeutics in a note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst A. Berens now forecasts that the company will post earnings of ($4.03) per share for the year, up from […]
